Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has released its financial and operational highlights for the first quarter of FY27 (Q1 FY27). The company reported a significant year-on-year increase in operating revenue and EBITDA, demonstrating continued growth. Key operational metrics such as IP and OP volumes also saw substantial improvements, reflecting strong patient throughput. These results provide insights into the company’s current performance and strategic direction.
KIMS Hospitals Presents Q1 FY27 Financial and Operational Highlights
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) has announced its financial and operational performance for the first quarter of the fiscal year 2027 (Q1 FY27), ending June 30, 2026. The company has reported a robust performance with notable increases in key financial and operational metrics.
Financial Performance
In terms of financial highlights, KIMS Hospitals recorded an Operating Revenue of ₹11,795 million for Q1 FY27. This represents a significant year-on-year (YoY) growth of 35.3% compared to Q1 FY26. Total Revenue also saw a strong increase of 36.1% YoY, reaching ₹11,959 million.
EBITDA for the quarter stood at ₹2,398 million, an increase of 20.1% YoY. The EBITDA margin was 20.1% of the total revenue.
Profit After Tax (PAT) was ₹374 million, although this reflects a decrease of 56.0% YoY, attributed partly to statutory impacts and fair valuation adjustments mentioned in the footnotes. Basic and Diluted EPS were ₹1.04 for the quarter.
Operational Highlights
Operationally, KIMS Hospitals experienced strong patient volumes. IP Volume grew by 26.6% YoY to 72,493. Similarly, OP Volume saw a 28.5% YoY increase, reaching 6,58,617.
Average Revenue Per Occupied Bed (ARPOB) was ₹47,200, up by 9.7% YoY. Average Revenue Per Patient (ARPP) also increased by 6.8% YoY to ₹1,63,573.
Key Takeaways
The presentation details the company’s growth trajectory, with sustained performance over two decades highlighted by strong CAGRs in revenue and EBITDA. Strategic levers for future growth, including expansion, acquisitions, doctor partnerships, and investor value creation, are also emphasized. The document provides a detailed breakdown of bed capacity, occupancy rates, and financial performance across various regions, underscoring the company’s extensive operational footprint and strategic expansion plans.
Source: BSE
